Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.43
CI's Cash to Debt is ranked lower than
76% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.61 vs. CI: 0.43 )
Ranked among companies with meaningful Cash to Debt only.
CI' s 10-Year Cash to Debt Range
Min: 0.28  Med: 0.82 Max: N/A
Current: 0.43
Equity to Asset 0.19
CI's Equity to Asset is ranked lower than
89% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.39 vs. CI: 0.19 )
Ranked among companies with meaningful Equity to Asset only.
CI' s 10-Year Equity to Asset Range
Min: 0.04  Med: 0.09 Max: 0.2
Current: 0.19
0.04
0.2
Interest Coverage 12.47
CI's Interest Coverage is ranked lower than
58% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.26 vs. CI: 12.47 )
Ranked among companies with meaningful Interest Coverage only.
CI' s 10-Year Interest Coverage Range
Min: 8.06  Med: 9.90 Max: 9999.99
Current: 12.47
8.06
9999.99
F-Score: 7
WACC vs ROIC
5.07%
14.95%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 9.21
CI's Operating margin (%) is ranked higher than
83% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.70 vs. CI: 9.21 )
Ranked among companies with meaningful Operating margin (%) only.
CI' s 10-Year Operating margin (%) Range
Min: 1.32  Med: 8.56 Max: 13.07
Current: 9.21
1.32
13.07
Net-margin (%) 5.87
CI's Net-margin (%) is ranked higher than
83% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.51 vs. CI: 5.87 )
Ranked among companies with meaningful Net-margin (%) only.
CI' s 10-Year Net-margin (%) Range
Min: -2.31  Med: 5.89 Max: 9.74
Current: 5.87
-2.31
9.74
ROE (%) 19.38
CI's ROE (%) is ranked higher than
85% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.50 vs. CI: 19.38 )
Ranked among companies with meaningful ROE (%) only.
CI' s 10-Year ROE (%) Range
Min: -9.89  Med: 17.80 Max: 30.77
Current: 19.38
-9.89
30.77
ROA (%) 3.75
CI's ROA (%) is ranked higher than
59% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.05 vs. CI: 3.75 )
Ranked among companies with meaningful ROA (%) only.
CI' s 10-Year ROA (%) Range
Min: -0.49  Med: 1.86 Max: 3.81
Current: 3.75
-0.49
3.81
ROC (Joel Greenblatt) (%) 244.89
CI's ROC (Joel Greenblatt) (%) is ranked higher than
79% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 85.50 vs. CI: 244.89 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 53.46  Med: 240.66 Max: 399.25
Current: 244.89
53.46
399.25
Revenue Growth (3Y)(%) 17.20
CI's Revenue Growth (3Y)(%) is ranked higher than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.30 vs. CI: 17.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CI' s 10-Year Revenue Growth (3Y)(%) Range
Min: -2.3  Med: 10.80 Max: 19
Current: 17.2
-2.3
19
EBITDA Growth (3Y)(%) 20.00
CI's EBITDA Growth (3Y)(%) is ranked higher than
75% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. CI: 20.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CI' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: 1.50 Max: 104.3
Current: 20
0
104.3
EPS Growth (3Y)(%) 19.00
CI's EPS Growth (3Y)(%) is ranked higher than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.30 vs. CI: 19.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CI' s 10-Year EPS Growth (3Y)(%) Range
Min: -32  Med: 6.50 Max: 79.5
Current: 19
-32
79.5
» CI's 10-Y Financials

Financials


Revenue & Net Income
Equity & Asset
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

CI Guru Trades in Q2 2014

Jim Simons 14,100 sh (New)
Joel Greenblatt 23,082 sh (New)
David Dreman 5,425 sh (+24.11%)
Dodge & Cox 6,049,387 sh (+12.62%)
Richard Pzena 5,281,715 sh (+9.51%)
Larry Robbins 2,226,626 sh (+8.09%)
James Barrow 2,884,758 sh (+3.15%)
Mario Gabelli 10,050 sh (unchged)
John Keeley 8,150 sh (unchged)
Pioneer Investments 77,400 sh (unchged)
Bill Frels 4,500 sh (-7.98%)
Vanguard Health Care Fund 6,163,900 sh (-8.03%)
David Einhorn 3,096,230 sh (-26.48%)
Ray Dalio 27,081 sh (-57.00%)
Paul Tudor Jones 8,000 sh (-60.22%)
Jeremy Grantham 5,000 sh (-93.75%)
» More
Q3 2014

CI Guru Trades in Q3 2014

Paul Tudor Jones 16,949 sh (+111.86%)
Dodge & Cox 10,321,737 sh (+70.62%)
Ray Dalio 31,781 sh (+17.36%)
Joel Greenblatt 25,743 sh (+11.53%)
Richard Pzena 5,584,763 sh (+5.74%)
James Barrow 2,927,567 sh (+1.48%)
David Dreman 5,442 sh (+0.31%)
Bill Frels 4,500 sh (unchged)
Ronald Muhlenkamp 60 sh (unchged)
Mario Gabelli 10,050 sh (unchged)
Vanguard Health Care Fund 6,163,900 sh (unchged)
Pioneer Investments 77,400 sh (unchged)
Larry Robbins 2,226,626 sh (unchged)
John Keeley 8,150 sh (unchged)
Jim Simons Sold Out
David Einhorn 2,073,800 sh (-33.02%)
Jeremy Grantham 2,700 sh (-46.00%)
» More
Q4 2014

CI Guru Trades in Q4 2014

Steven Cohen 34,300 sh (New)
Andreas Halvorsen 182,761 sh (New)
Jim Simons 256,000 sh (New)
Joel Greenblatt 54,267 sh (+110.80%)
Dodge & Cox 10,351,758 sh (+0.29%)
Bill Frels 4,500 sh (unchged)
Vanguard Health Care Fund 6,163,900 sh (unchged)
Ronald Muhlenkamp 60 sh (unchged)
Mario Gabelli 10,050 sh (unchged)
David Einhorn Sold Out
Pioneer Investments 76,611 sh (-1.02%)
John Keeley 7,750 sh (-4.91%)
Richard Pzena 5,158,791 sh (-7.63%)
Ray Dalio 26,981 sh (-15.10%)
James Barrow 2,474,960 sh (-15.46%)
Jeremy Grantham 2,200 sh (-18.52%)
Larry Robbins 1,680,126 sh (-24.54%)
David Dreman 4,098 sh (-24.70%)
Paul Tudor Jones 9,187 sh (-45.80%)
» More
Q1 2015

CI Guru Trades in Q1 2015

Louis Moore Bacon 8,196 sh (New)
Signature Select Canadian Fund 15,600 sh (New)
Ronald Muhlenkamp 2,100 sh (New)
Steven Cohen 275,600 sh (+703.50%)
Larry Robbins 1,778,837 sh (+5.88%)
Joel Greenblatt 55,057 sh (+1.46%)
James Barrow 2,478,001 sh (+0.12%)
Mario Gabelli 10,050 sh (unchged)
John Keeley 7,750 sh (unchged)
Bill Frels 4,500 sh (unchged)
Vanguard Health Care Fund 6,163,900 sh (unchged)
Jeremy Grantham 2,200 sh (unchged)
Jim Simons Sold Out
Andreas Halvorsen Sold Out
Dodge & Cox 10,315,208 sh (-0.35%)
Richard Pzena 4,718,281 sh (-8.54%)
Pioneer Investments 58,682 sh (-23.40%)
Ray Dalio 20,345 sh (-24.60%)
Paul Tudor Jones 6,800 sh (-25.98%)
David Dreman 1,786 sh (-56.42%)
» More
» Details

Insider Trades

Latest Guru Trades with CI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 20.34
CI's P/E(ttm) is ranked higher than
78% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 30.10 vs. CI: 20.34 )
Ranked among companies with meaningful P/E(ttm) only.
CI' s 10-Year P/E(ttm) Range
Min: 3.24  Med: 10.92 Max: 21.45
Current: 20.34
3.24
21.45
Forward P/E 16.69
CI's Forward P/E is ranked higher than
67% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.99 vs. CI: 16.69 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 20.50
CI's PE(NRI) is ranked higher than
78% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 30.30 vs. CI: 20.50 )
Ranked among companies with meaningful PE(NRI) only.
CI' s 10-Year PE(NRI) Range
Min: 3.23  Med: 11.35 Max: 21.51
Current: 20.5
3.23
21.51
P/B 3.77
CI's P/B is ranked lower than
78% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.89 vs. CI: 3.77 )
Ranked among companies with meaningful P/B only.
CI' s 10-Year P/B Range
Min: 0.52  Med: 2.13 Max: 3.96
Current: 3.77
0.52
3.96
P/S 1.18
CI's P/S is ranked lower than
75% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.61 vs. CI: 1.18 )
Ranked among companies with meaningful P/S only.
CI' s 10-Year P/S Range
Min: 0.13  Med: 0.65 Max: 1.26
Current: 1.18
0.13
1.26
PFCF 25.52
CI's PFCF is ranked lower than
67% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.56 vs. CI: 25.52 )
Ranked among companies with meaningful PFCF only.
CI' s 10-Year PFCF Range
Min: 1.8  Med: 13.61 Max: 149.61
Current: 25.52
1.8
149.61
POCF 19.77
CI's POCF is ranked lower than
70% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.37 vs. CI: 19.77 )
Ranked among companies with meaningful POCF only.
CI' s 10-Year POCF Range
Min: 1.52  Med: 10.25 Max: 46.5
Current: 19.77
1.52
46.5
EV-to-EBIT 12.31
CI's EV-to-EBIT is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.50 vs. CI: 12.31 )
Ranked among companies with meaningful EV-to-EBIT only.
CI' s 10-Year EV-to-EBIT Range
Min: 3.3  Med: 8.15 Max: 17.6
Current: 12.31
3.3
17.6
PEG 1.69
CI's PEG is ranked higher than
53% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.69 vs. CI: 1.69 )
Ranked among companies with meaningful PEG only.
CI' s 10-Year PEG Range
Min: 0.3  Med: 0.69 Max: 5.06
Current: 1.69
0.3
5.06
Shiller P/E 27.47
CI's Shiller P/E is ranked higher than
59% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 28.42 vs. CI: 27.47 )
Ranked among companies with meaningful Shiller P/E only.
CI' s 10-Year Shiller P/E Range
Min: 2.63  Med: 14.37 Max: 28.83
Current: 27.47
2.63
28.83
Days Sales Outstanding 33.66
CI's Days Sales Outstanding is ranked lower than
71% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 24.93 vs. CI: 33.66 )
Ranked among companies with meaningful Days Sales Outstanding only.
CI' s 10-Year Days Sales Outstanding Range
Min: 22.27  Med: 48.24 Max: 325.78
Current: 33.66
22.27
325.78

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.02
CI's Dividend Yield is ranked lower than
100% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.20 vs. CI: 0.02 )
Ranked among companies with meaningful Dividend Yield only.
CI' s 10-Year Dividend Yield Range
Min: 0.02  Med: 0.09 Max: 1.2
Current: 0.02
0.02
1.2
Dividend Payout 0.01
CI's Dividend Payout is ranked higher than
90% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.25 vs. CI: 0.01 )
Ranked among companies with meaningful Dividend Payout only.
CI' s 10-Year Dividend Payout Range
Min: 0  Med: 0.18 Max: 0.69
Current: 0.01
0
0.69
Yield on cost (5-Year) 0.02
CI's Yield on cost (5-Year) is ranked lower than
100% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.88 vs. CI: 0.02 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CI' s 10-Year Yield on cost (5-Year) Range
Min: 0.02  Med: 0.09 Max: 1.2
Current: 0.02
0.02
1.2
Share Buyback Rate 0.30
CI's Share Buyback Rate is ranked higher than
65% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.60 vs. CI: 0.30 )
Ranked among companies with meaningful Share Buyback Rate only.
CI' s 10-Year Share Buyback Rate Range
Min: 11.9  Med: 4.60 Max: -1.7
Current: 0.3

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 8.39
CI's Price/Tangible Book is ranked lower than
69% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.07 vs. CI: 8.39 )
Ranked among companies with meaningful Price/Tangible Book only.
CI' s 10-Year Price/Tangible Book Range
Min: 1.31  Med: 3.84 Max: 27.98
Current: 8.39
1.31
27.98
Price/Projected FCF 1.58
CI's Price/Projected FCF is ranked lower than
74% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.06 vs. CI: 1.58 )
Ranked among companies with meaningful Price/Projected FCF only.
CI' s 10-Year Price/Projected FCF Range
Min: 0.28  Med: 1.05 Max: 4.89
Current: 1.58
0.28
4.89
Price/Median PS Value 1.84
CI's Price/Median PS Value is ranked lower than
100% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.10 vs. CI: 1.84 )
Ranked among companies with meaningful Price/Median PS Value only.
CI' s 10-Year Price/Median PS Value Range
Min: 0.38  Med: 1.04 Max: 1.69
Current: 1.84
0.38
1.69
Price/Peter Lynch Fair Value 1.42
CI's Price/Peter Lynch Fair Value is ranked higher than
92% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.81 vs. CI: 1.42 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.35  Med: 0.58 Max: 2.96
Current: 1.42
0.35
2.96
Price/Graham Number 2.71
CI's Price/Graham Number is ranked higher than
64% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.91 vs. CI: 2.71 )
Ranked among companies with meaningful Price/Graham Number only.
CI' s 10-Year Price/Graham Number Range
Min: 0.77  Med: 1.48 Max: 3.81
Current: 2.71
0.77
3.81
Earnings Yield (Greenblatt) (%) 8.17
CI's Earnings Yield (Greenblatt) (%) is ranked higher than
71% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.30 vs. CI: 8.17 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CI' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 5.7  Med: 12.30 Max: 29.9
Current: 8.17
5.7
29.9
Forward Rate of Return (Yacktman) (%) 17.12
CI's Forward Rate of Return (Yacktman) (%) is ranked higher than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.12 vs. CI: 17.12 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CI' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -3.3  Med: 16.30 Max: 46.7
Current: 17.12
-3.3
46.7

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:UNH, ESRX, WLP, HUM, AET » details
Traded in other countries:CGN.Germany,
Cigna Corp was incorporated in the State of Delaware in 1981. It is a health services organization with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services. In the U.S., the majority of these products and services are offered through employers and other groups and, in selected international markets. It offers supplemental health, life and accident insurance products and international health care coverage and services to businesses, governmental and non-governmental organizations and individuals. The Company's segments are Global Health Care, Group Disability and Life, Global Supplemental Benefits, Run-off Reinsurance and Other Operations including Corporate-owned Life Insurance. The Global Health Care aggregates two operating segments namely Commercial that includes the international health care business and Government. The Company's Global Health Care segment offers insured and self-funded medical, dental, behavioral health, vision, and prescription drug benefit plans, health advocacy programs and other products and services that might be integrated to provide individuals with complete health care benefit programs. The Company's Group Disability and Life segment provides the insurance products and their related services such as group life insurance, long-term and short-term disability insurance, workers' compensation and disability case management, and accident and specialty insurance. The Global Supplemental Benefits segment is comprised of the international supplemental health, life and accident businesses as well as the Medicare supplement business. This segment offers supplemental health, life and accident insurance products in the U.S. and selected international markets. With local licenses and partnerships in approximately 20 countries and jurisdictions, it is able to offer products and services to local citizens and in other international markets. These products and services are provided by subsidiaries of the Company, including foreign operating entities. The products and services related to these operations were offered by subsidiaries of Cigna Corporation. Other Operations of the Company consists of: non-leveraged and leveraged corporate-owned life insurance; deferred gains recognized from the sale of the individual life insurance and annuity business and the sale of the retirement benefits business and run-off settlement annuity business. The Company's International's life, accident and supplemental health insurance products are sold mainly through direct marketing channels, such as outbound telemarketing, in-branch bancassurance and direct response television. In the HealthCare business, it competes with: insurance companies that provide group health and life insurance products, Blue Cross and Blue Shield organizations; stand-alone HMOs and PPOs; HMOs affiliated with insurance companies and hospitals and national managed pharmacy, beh
» More Articles for CI

Headlines

Articles On GuruFocus.com
Dodge & Cox Global Stock Fund First Quarter 2015 Commentary Apr 24 2015 
Dodge & Cox Stock Fund First Quarter 2015 Commentary Apr 24 2015 
Cigna Offers Growth, Value, And A Track Record Of Crushing Analyst Estimates Apr 20 2015 
UnitedHealth Group Is Ready For A Huge Pharmacy Deal Apr 06 2015 
Aetna: Solid Prospects in a Volatile Environment Mar 31 2015 
Weekly CEO Sells Highlight: Six Flags Entertainment Corp, Tableau Software Inc, Cigna Corp, and Nuan Feb 21 2015 
UNH: A Strong Candidate for Income and Capital Appreciation Dec 12 2014 
UnitedHealth Releases Optimistic Outlook with Oppenheimer Reiterating an Outperform Rating Dec 04 2014 
Weekly 52-Week Highs Highlight: WYN, WMT, PLD, CI Nov 29 2014 
Cigna and Liazon Join Together to Offer Suite of Products on Liazon's Leading Private Exchange Platf Oct 15 2014 

More From Other Websites
Florida Cancer Specialists and Cigna Collaborate to Improve Care for People Fighting Cancer Jul 07 2015
Florida Cancer Specialists and Cigna Collaborate to Improve Care for People Fighting Cancer Jul 07 2015
Jack Levy's Swan Song: Selling Humana Jul 07 2015
MOVES-Bupa Global names Sheldon Kenton as global commercial director Jul 07 2015
Aetna CEO addresses antitrust concerns over Humana deal Jul 06 2015
US stocks fall after Greek vote Jul 06 2015
4 Stocks, 4 trades: GPRO, TRIP, WTW & AET Jul 06 2015
US stocks drop after Greek vote Jul 06 2015
The $37B merger that can affect your health Jul 06 2015
US stocks down about 0.6% after Greek vote Jul 06 2015
Humana Cuts Outlook After Aetna Announces Buyout Jul 06 2015
Faber Report: Aetna-Humana merger Jul 06 2015
Aetna's Humana Deal Pressures Cigna to Agree on Anthem Offer Jul 06 2015
Health care's urge to merge Jul 06 2015
Deals of the Day: Latest on the Health-Insurer Front, Samsung Setback Jul 06 2015
5 Best-Performing S&P 500 Stocks Of 2015 Jul 06 2015
Insurance mergers getting hot Jul 06 2015
With Merger Deal, Aetna, Humana Get Ahead of the Pack Jul 05 2015
Aetna, Humana Hurry to the Altar Jul 05 2015
Rivals Lurked Behind Aetna's Deal With Humana Jul 03 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK